The Valley Desk

NCT00074984 · Interventional trial

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

Overall registry status Completed

Phase 4

Conditions Fabry Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov